In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV, and HCV), performed on the Tigris testing platform, to the newer Ultrio Elite triplex assay, and performed on the Panther testing platform. The CTS Phoenix lab will implement first on July 7th, with the 4 remaining CTS labs located in Charlotte, Dallas, St. Louis amd Tampa all implementing on July 13, 2020.
Click here for all the details: Communications
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
We are very excited to launch our new website! Please take a few moments to click around and explore...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...